About: Treatment outcomes and prognostic factors of medication-related osteonecrosis of the jaw: a case- and literature-based review

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treatment outcomes and prognostic factors of medication-related osteonecrosis of the jaw: a case- and literature-based review Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 08 November 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 2018 (uk) article scientifique publié en 2018 (fr) artículu científicu espublizáu en payares de 2018 (ast) scientific article published on 08 November 2018 (en)
publication date	wds:Q58578247-EB0FF2F2-5A0D-47F6-ABA3-45907ACFFF20
publication date	2018-11-08 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58578247-91CE99B7-06A2-4AEB-A3F3-1D08AE83A747
language of work or name	English
cites work	wds:Q58578247-02D041AC-8000-48B6-8AE7-19C939550DC5 wds:Q58578247-03919EED-AD44-4AE2-A276-3CE6AE65270D wds:Q58578247-15F5E9B6-8AA7-44CC-AF4A-6C50D8CB786F wds:Q58578247-160388A6-319A-44C6-97A1-137D8D289015 wds:Q58578247-192C9E29-FA50-4A1F-8F83-112486096905 wds:Q58578247-1ADA51B0-6783-42A6-9050-DDE9DC026BCE wds:Q58578247-21E063B3-59AF-4C05-9529-3D3609E74293 wds:Q58578247-26F3DAFD-7BD9-4125-9F71-26B156C8ABBB wds:Q58578247-2F0B7629-5697-4434-9F41-BA150C40E9EC wds:Q58578247-2FBB98F9-C8AC-4851-BE2F-68DB9E4EAF03 wds:Q58578247-4C4019AE-CD0D-4136-84E6-920C88148387 wds:Q58578247-4C98952C-FD5C-4FF6-9011-18271DDA43F6 wds:Q58578247-51D6D6DB-1480-4B22-96F6-909CC580B4F4 wds:Q58578247-54603D84-88F0-4C4E-BDAB-3E890E145BC1 wds:Q58578247-57652AFA-858F-4A1F-974D-DA7CACE9BA1E wds:Q58578247-589CE7CC-CEA4-475E-942C-2198E46E6692 wds:Q58578247-65CCDFE4-B10C-4F69-A570-5684E316BE79 wds:Q58578247-66043CAE-0DE8-4EF6-96A5-46482745A417 wds:Q58578247-87016447-1E37-43DE-83EA-AE669EDAFCE9 wds:Q58578247-94115987-922C-4BEA-8528-17E7084A8D90 wds:Q58578247-97E06994-A555-4F3C-B37E-DE498274DAB1 wds:Q58578247-9C4D7B24-7D8F-43E1-A7BE-85D9DD2B4930 wds:Q58578247-9DE8FD0E-E513-4412-9859-29E20DD83762 wds:Q58578247-A33CBF38-8DAC-44D9-AC21-9105748A5F8C wds:Q58578247-B0D00B09-4BFF-4C75-BBFB-1B6F6D3BF4E8 wds:Q58578247-B5B01927-5E3B-4380-895B-1EA51961694D wds:Q58578247-BACB0D5D-4042-486F-A428-8454D43DE0B6 wds:Q58578247-BB1A75E9-571A-4292-847C-ED5EDD1014DE wds:Q58578247-BF9A38EE-4EE1-4AB7-9489-0EDE11A76D24 wds:Q58578247-C941DEFE-E104-4C9B-9CF2-48B0F2731999 wds:Q58578247-CBCD1E9C-A67A-4DD9-82DD-B063BF37D9DC wds:Q58578247-CEC9A79F-5B30-48F5-BF60-04F112AAAB3C wds:Q58578247-DB880676-C168-42B0-A1C7-CB6F8D7A5550 wds:Q58578247-DD2B356B-099D-4FAD-B9F8-BA0F2A32A997 wds:Q58578247-DDB52E3A-D12C-4A93-8E4C-7821C50FD102 wds:Q58578247-E3552006-0A80-4DA8-8332-FF4226EA42CC wds:Q58578247-E88BADFB-CB89-4F95-82F6-D4630FB243B0 wds:Q58578247-ED2C3315-40CA-4B56-9403-264FCF5872EA wds:Q58578247-F4151C48-7E48-4ACD-9B49-132BE07C8F5D wds:Q58578247-F45FB621-4CFE-4521-89D8-4853FF7582D4
cites work	American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw. Vertebral fracture prevalence in women in Hiroshima compared to Caucasians or Japanese in the US Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update Bisphosphanates and Oral Cavity Avascular Bone Necrosis Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Max A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials. Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up. Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update Natural History of Osteonecrosis of the Jaw in Patients With Multiple Myeloma Surgical management of bisphosphonate induced osteonecrosis of the jaws Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator. Fluorescence-guided bone resection in bisphosphonate-associated osteonecrosis of the jaws Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. The outcome after surgical therapy of bisphosphonate-associated osteonecrosis of the jaw—results of a clinical case series with an average follow-up of 20 months Extensive Surgical Procedures Result in Better Treatment Outcomes for Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Osteoporosis. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution. Surgical treatment vs. conservative treatment in intravenous bisphosphonate-related osteonecrosis of the jaws. Systematic review. Prognosis factors in the treatment of bisphosphonate-related osteonecrosis of the jaw - Prognostic factors in the treatment of BRONJ. Evaluation of the predisposing factors and involved outcome of surgical treatment in bisphosphonate-related osteonecrosis of the jaw cases including bone biopsies. Bisphosphonate-related osteonecrosis of the jaws: Cohort study of surgical treatment results in seventy-four stage II/III patients. Clinical utility of three-dimensional SPECT/CT imaging as a guide for the resection of medication-related osteonecrosis of the jaw. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws
author name string	wds:Q58578247-0A1F989B-9A7B-4654-998B-F0E3CA79D6D5 wds:Q58578247-19000BAE-9325-4A8A-8240-50C2A008306A wds:Q58578247-5FF741FF-3B76-4F23-8F95-3F15D0A602A4 wds:Q58578247-7D9F57D9-C853-4E8C-935B-7921BA87A29D wds:Q58578247-93AF6D20-4CD0-423D-8C33-180B43F56C7D wds:Q58578247-9C384280-EAC6-4DE1-9B18-1C61DA8092E1 wds:Q58578247-BA590468-E950-43A9-BA0C-520D69D95CCC wds:Q58578247-CD4C45B0-5DA1-415F-8A6A-B18541F7E98D wds:Q58578247-CE52F1A3-1A93-4AB3-85CB-A12E82C3C751
author name string	Shigeru Suzuki

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software